Back to discover
Drug

Poloxamer

Research stage
Emerging research

Also known as Poloxamers.

1
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Poloxamer
Aliases & brands
Poloxamers
RxNorm CUI
155156

Research activity

1 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Journals, researchers & institutions
Top journals
  • Nature communications1
Leading researchers
  • Guo B1
  • Liang Y1
  • Ma PX1
  • Wu H1
  • Zhao X1
Leading institutions
free-text, unnormalised
  • Frontier Institute of Science and Technology and State Key Laboratory for Mechanical Behavior of Materials1
  • Macromolecular Science and Engineering Center1
  • the First Affiliated Hospital1
  • University of Michigan1

Related drugs

2 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Studied across 2 of the same disease areas as Poloxamer in the shared literature.

2 shared diseases1 shared paper

Studied across 2 of the same disease areas as Poloxamer in the shared literature.

2 shared diseases1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • Europe PMC — research literature